NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Faes Farma S.A (MC: FAE)

 
FAE Technical Analysis
1
As on 7th Jul 2023 FAE STOCK Price closed @ 3.13 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

FAESTOCK Price

Open 3.13 Change Price %
High 3.15 1 Day N/A N/A
Low 3.12 1 Week 0.00 0.00
Close 3.13 1 Month 0.00 0.00
Volume 172424 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
MC Spain Most Active Stocks
UBS 0.01 %
DIA 0.01 %
SAN 3.26 %
SAB 1.09 %
IBE 11.19 %
TEF 3.63 %
UNI 0.96 %
BKY 0.41 %
BBVA 6.89 %
AI 0.11 %
 
MC Spain Top Gainers Stocks
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
VER 3.70 0.54%
 
MC Spain Top Losers Stocks
CDR 0.09 -30.77%
CDR 0.09 -30.77%
CDR 0.09 -30.77%
CDR 0.09 -30.77%
SPS 0.84 -1.18%
RDM 1.44 -0.69%
RDM 1.44 -0.69%
REE 19.11 -0.52%
REE 19.11 -0.52%
REE 19.11 -0.52%
 
 
FAE
Daily Charts
FAE
Intraday Charts
Whats New @
Bazaartrend
FAE
Free Analysis
 
FAE Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
FAE Forecast October 2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
FAE Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
FAE Forecast2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
Faes Farma S.A ( MC Spain Symbol : FAE )
Sector : Healthcare And Other Stocks in Same Sector
 
FAE Other Details
Segment EQ
Market Capital 1020962304.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
FAE Address
FAE
 
FAE Latest News
 
Your Comments and Response on Faes Farma S.A
 
FAE Business Profile
Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. It also exports its products. Faes Farma, S.A. was founded in 1933 and is headquartered in Leioa, Spain. Address: Avenida Autonomía 10, Leioa, Spain, 48940
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service